Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study

Risultato della ricerca: Contributo in rivistaArticolo in rivista

10 Citazioni (Scopus)

Abstract

Atazanavir and lopinavir represent the main HIV protease inhibitors recommended in pregnancy, but comparative data in pregnant women are limited.
Lingua originaleEnglish
pagine (da-a)1377-1384
Numero di pagine8
RivistaJournal of Antimicrobial Chemotherapy
Volume69
DOI
Stato di pubblicazionePubblicato - 2014

Keywords

  • Adult
  • Anti-HIV Agents
  • CD4 Lymphocyte Count
  • Female
  • HIV Infections
  • HIV RNA
  • Humans
  • Lipids
  • Liver Function Tests
  • Lopinavir
  • Oligopeptides
  • Pregnancy
  • Pregnancy Complications, Infectious
  • Pregnancy Outcome
  • Pyridines
  • RNA, Viral
  • Viral Load
  • bilirubin
  • cholesterol
  • pre-term delivery
  • triglycerides

Fingerprint

Entra nei temi di ricerca di 'Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study'. Insieme formano una fingerprint unica.

Cita questo